Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrug ▼Date fromSubject
 20.3.2024STALLERGENES (SLG-1)8174DACTAIR 300 IR sublingválne tablety (tbl slg 30x300 IR (blis.OPA/Al/PVC/Al))21.3.2024O
 27.2.2024STALLERGENES (SLG-1)8174DACTAIR 300 IR sublingválne tablety (tbl slg 30x300 IR (blis.OPA/Al/PVC/Al))28.2.2024R
 22.3.2024STALLERGENES (SLG-1)8175DACTAIR 300 IR sublingválne tablety (tbl slg 90x300 IR (blis.OPA/Al/PVC/Al))23.3.2024O
 13.2.2024STALLERGENES (SLG-1)8175DACTAIR 300 IR sublingválne tablety (tbl slg 90x300 IR (blis.OPA/Al/PVC/Al))14.2.2024R
 10.1.2024STALLERGENES (SLG-1)8175DACTAIR 300 IR sublingválne tablety (tbl slg 90x300 IR (blis.OPA/Al/PVC/Al))12.6.2023O
 29.5.2023STALLERGENES (SLG-1)8175DACTAIR 300 IR sublingválne tablety (tbl slg 90x300 IR (blis.OPA/Al/PVC/Al))29.5.2023R
 27.11.2019Actavis Group PTC ehf. (ACT-5)20474Actamone 10 mg (tbl flm 28x10 mg (blis.OPA/Al/PVC/Al))28.2.2020Z
 27.11.2019Actavis Group PTC ehf. (ACT-5)20478Actamone 10 mg (tbl flm 98x10 mg (blis.OPA/Al/PVC/Al))31.1.2020Z
 28.9.2022Actavis Group PTC ehf. (ACT-10)4637AActelsar HCT 80 mg/12,5 mg tablety (tbl 90x80 mg/12,5 mg (blis.Al/Al))7.10.2022O
 7.12.2023Actavis Group PTC ehf. (ACT-10)4637AActelsar HCT 80 mg/12,5 mg tablety (tbl 90x80 mg/12,5 mg (blis.Al/Al))5.1.2024R
 2.8.2022Actavis Group PTC ehf. (ACT-10)4637AActelsar HCT 80 mg/12,5 mg tablety (tbl 90x80 mg/12,5 mg (blis.Al/Al))15.9.2022R
 12.1.2024Actavis Group PTC ehf. (ACT-10)4637AActelsar HCT 80 mg/12,5 mg tablety (tbl 90x80 mg/12,5 mg (blis.Al/Al))12.1.2024O
 27.4.2023Actavis Group PTC ehf. (ACT-5)4648AActelsar HCT 80 mg/25 mg tablety (tbl 28x80 mg/25 mg (blis.Al/Al))27.4.2023O
 2.8.2022Actavis Group PTC ehf. (ACT-5)4648AActelsar HCT 80 mg/25 mg tablety (tbl 28x80 mg/25 mg (blis.Al/Al))31.8.2022R
 29.8.2022Novo Nordisk A/S (NOO)41355Actrapid Penfill 100 medzinárodných jednotiek/ml injekčný roztok v náplni (sol inj 10x3 ml/300 IU (3,5 mg/ ml) (skl.náplň))29.8.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)